Brendan Kelly, PhD
Login to view DISC.Brendan Kelly is a Principal at Lightstone Ventures, specializing in life sciences strategy for pharmaceutical and biotechnology firms. A PhD in computational chemistry from Trinity College Dublin, he co-founded A2A Pharmaceuticals and has extensive experience in drug discovery, having collaborated with companies like Pfizer and Eli Lilly.
He is the co-founder of A2A Pharmaceuticals, a company using computational drug discovery to create new therapeutics for oncology and drug-resistant bacterial infections.
Read the full overview →How Brendan shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Brendan cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.